ARTICLE | Company News
Avrobio acquires cystinosis program from GenStem
December 1, 2017 9:41 PM UTC
In October, GenStem Therapeutics Inc. (San Diego, Calif.) granted Avrobio Inc. (Cambridge, Mass.) exclusive, worldwide rights to cystinosis gene therapy AVR-RD-04. Financial details are not disclosed...